about
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute DecompensatedTorsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)Techniques and applications of perioperative therapeutic plasma exchange.Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs.Medical management of patients with continuous-flow left ventricular assist devices.Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilizationDecongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failureVentricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart Study.The Impact of Worsening Heart Failure in the United StatesDifferences in health care use and outcomes by the timing of in-hospital worsening heart failure.High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) RegistryTrends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure RegistryHospitalizations in patients with atrial fibrillation: an analysis from ROCKET AFAssessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure.Thinking Outside the Box: Treating Acute Heart Failure Outside the Hospital to Improve Care and Reduce Admissions.Angiotensin receptor neprilysin inhibition in heart failure: mechanistic action and clinical impact.Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE).Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF.Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure.Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure.Getting to a Man's Heart through His Colon.Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.Transient and persistent worsening renal function during hospitalization for acute heart failure.Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes.Patient selection for advanced heart failure therapy referral.Measuring heart failure quality: does perfection matter?Response to Letter Regarding Article, "Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure.Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.Predictors of hypertension control in a diverse general cardiology practice.A Machine Without an Owner's Manual.Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient.Heart failure medications prescribed at discharge for patients with left ventricular assist devices.Ascending aorta to main pulmonary artery fistula following orthotopic heart transplantation: successful percutaneous closure employing an Amplatzer Duct Occluder.Selecting a noninvasive imaging study after an inconclusive exercise test.Embolism after inferior vena cava filter mesh fragmentation.
P50
Q27340297-654397BB-6EE2-47B0-8A8F-A1EDC61A9423Q28271500-85654996-3DED-4925-90EF-2C5A3975CBC0Q33412099-CBEB8801-6356-4734-8CE2-77414E3C25F1Q33677364-691A4381-D521-4232-8E6C-43660F3E9DA7Q34152572-D701BA21-3AE0-4610-9763-6716A5EE6B04Q34675031-B122FE42-36B7-4DEB-97AD-1CE8398D13A8Q35026394-A3CC3AF1-0717-40EB-82B8-FBB3204B2ECAQ35071595-62401264-9751-4CD0-A8C9-12352C25F9BDQ35251451-D2B790CD-FF4C-4115-B79B-9B85345744F1Q36168137-F272FD26-595B-427B-A051-0CF89A50788CQ36385581-B5E9AE15-C788-46AD-94DA-25B8EC4604CEQ37029809-6CC80C5F-5063-47A5-A92E-E018D452CA57Q37055598-4C20035A-0ADC-421A-A405-11B84E01763EQ37153930-31A88C75-C669-48DB-971F-44CCDE6979DDQ37514357-ED7F96A8-3D3A-4A2E-A8FA-4348044CBFAFQ38408017-3F8B2F83-33AE-47DC-B896-5B0F8A4A57B7Q38501985-2F50E5AA-835D-4669-8DA6-C46BBB5CE0E4Q38553752-ABDF9966-4E66-48F1-9B3C-F22E34B3489CQ39510674-34736BCF-57A5-4591-B626-E5E7E87282B0Q39806082-100D43B4-EA15-4283-8D79-62AF10ED32E0Q39964810-254CE1F6-71F5-4957-885F-3B52A7F99C35Q40024666-1E06C878-EEAA-48D9-A1C0-A6A89F23E0D5Q40120285-3EEE941D-4A5C-470E-9014-0B6D339B57EEQ40168931-340AD920-7448-4718-B4B0-DB50A2460859Q40188410-9D1CD3C8-D15E-402E-8B31-7BE37F4A0E1FQ40694322-CEC206A2-5E56-4A6A-A6AF-0AFD07DC0B2CQ41529816-620C0D66-7BEC-4279-A289-685F12F303C8Q41744510-FFC1F442-C199-415E-97CD-B1B7D54249ADQ41908588-926A3994-F0E3-4306-B49A-096BB401840DQ42064867-3B0D8ADD-2BCD-4CDA-84D6-BE9062FE110FQ44732602-CC2FAE25-3869-4C89-A7ED-21961689D27FQ46099154-51E1B65F-01B3-4014-873B-560A13E0FC33Q46119393-FE0FF7B5-ECEC-4823-8B97-EEE20CB0F835Q46225244-F730662D-22FB-46C7-93DA-A3ACFF9170F0Q47325772-182741DF-EA2B-44F9-8A16-D893F8B58763Q47417995-8D13527E-B18D-480D-8C93-6BC57D99D5ABQ51172699-3A56419F-1E4F-4774-9656-B0A38A33DDE3Q53074265-EB0E286B-3286-440C-894D-8AA2EA2E381BQ53267182-E95F540E-734B-4063-A4E5-2D541AD7798EQ53269162-530A3536-16F0-4219-93DA-1F866B05861F
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Adam D. DeVore
@ast
Adam D. DeVore
@en
Adam D. DeVore
@es
Adam D. DeVore
@nl
type
label
Adam D. DeVore
@ast
Adam D. DeVore
@en
Adam D. DeVore
@es
Adam D. DeVore
@nl
prefLabel
Adam D. DeVore
@ast
Adam D. DeVore
@en
Adam D. DeVore
@es
Adam D. DeVore
@nl
P214
P106
P1153
36237400300
P21
P214
P31
P496
0000-0002-4679-2221
P735
P7859
lccn-no00033520